> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Inspection of Denmark Monkeypox Vaccine Facility Completed
- URL: https://www.fdaweb.com/inspection-of-denmark-monkeypox-vaccine-facility-completed/
- Published: 2022-07-14T12:00:00.000Z
- Updated: 2026-09-14T17:51:51.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5152282

FDA has completed an inspection in Denmark of Bavarian Nordic’s monkeypox vaccine manufacturing plant, a step that will lead to the release of thousands of doses for shipping to the U.S., according to an [AP report](https://apnews.com/article/science-health-new-york-city-875c6771d5fc9b97933c341c3a22714f?ref=fdaweb.com). A recent investigative article in *New York Magazine* criticized the agency’s foot dragging in performing the inspection as cases have risen in the U.S. and vaccines are in short supply.

“As monkeypox cases have ticked up nationwide, the White House and federal agencies have repeatedly assured the public that millions of vaccine doses will be distributed to at-risk populations before the end of the year,” the [article](https://nymag.com/intelligencer/2022/07/monkeypox-vaccine-delayed-after-fda-waited-to-inspect-plant.html?ref=fdaweb.com) said. “Yet since the World Health Organization announced the global monkeypox outbreak in May, only tens of thousands of shots have been administered in the U.S. The slow start is due, at least in part, to the fact that 1.1 million doses have been stored in a Denmark pharmaceutical facility while FDA has taken almost two months to approve their release here, according to people familiar with the situation.”

An FDA spokeswoman told the AP that agency investigators “expedited and completed an inspection of the company’s plant,” adding that there should be no expected delay in vaccine availability due to this process.